Stent vs. brachytherapy: Does life expectancy help you decide?

Gastrointestinal Endoscopy

Volumn 62, Issue 3, 2005, Pages 341-343

  Wallace, Michael B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; DYSPHAGIA; EDITORIAL; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LIVER METASTASIS; LUNG CANCER; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL; STENT; VALIDATION PROCESS;

BRACHYTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; STENTS; SURVIVAL ANALYSIS;

EID: 23944445341     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2005.06.007     Document Type: Editorial

References (12)

1. Steyerberg E.W., Homs M.Y.V., Stokvis A., Essink-Bot M.L., and Siersma P.D. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection Gastrointest Endosc 62 2005 333 340
2. C.R. Hayter, C. Huff-Winters, L. Paszat, Y.M. Youssef, W.E. Shelley, and K. Schulze A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer Radiother Oncol 56 2000 329 333
3. V. Sharma, U. Mahantshetty, K.A. Dinshaw, R. Deshpande, and S. Sharma Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 52 2002 310 315
4. R.K. Sur, B. Donde, V.C. Levin, and A. Mannell Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer Int J Radiat Oncol Biol Phys 40 1998 447 453
5. R.K. Sur, C.V. Levin, B. Donde, V. Sharma, L. Miszczyk, and S. Nag Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma: an International Atomic Energy Agency study Int J Radiat Oncol Biol Phys 53 2002 127 133
6. Cancer information for health professionals. 2005. Available at: www.cancer.gov/cancertopics/pdq/treatment/esophageal/healthprofessional. Accessed July 14, 2005.
7. A. Maier, F. Tomaselli, F. Gebhard, P. Rehak, J. Smolle, and F.M. Smolle-Juttner Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation Ann Thorac Surg 69 2000 1006 1009
8. K. Kaneko, H. Ito, K. Konishi, T. Kurahashi, T. Ito, and A. Katagiri Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus Br J Cancer 88 2003 18 24
9. A. Herskovic, K. Martz, M. al-Sarraf, L. Leichman, J. Brindle, and V. Vaitkevicius Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus [see comments] N Engl J Med 326 1992 1593 1598
10. M. Yakami, M. Mitsumori, H. Sai, Y. Nagata, M. Hiraoka, and Y. Nishimura Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer Int J Clin Oncol 8 2003 395 398
11. P.D. Siersema, S.L. Schrauwen, M. van Blankenstein, E.W. Steyerberg, A. van der Gaast, and H.W. Tilanus Self-expanding metal stents for complicated and recurrent esophagogastric cancer Gastrointest Endosc 54 2001 579 586
12. M.Y. Homs, B.E. Hansen, M. van Blankenstein, J. Haringsma, E.J. Kuipers, and P.D. Siersema Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma Eur J Gastroenterol Hepatol 16 2004 163 170